Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: jayhawk969 who wrote (1008)	5/1/2001 2:49:40 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3158

Tuck points to an article today (valuation thread) that points in turn at a DDDP deal. IMO, DDDP would make a wonderful little munch, for a biotech-biotech variation on the theme. With another company that has the same sort of leverage. NBIX-like leverage, behind a clinical pipe or discounted toward cash in hand with great preclinicals........ how many have we got? In a way, we could consider this class of potential munches as "LKST-like". NBIX, of course, has more leverage than did LKST.